secwatch / observer
8-K filed January 10, 2025, 6:59 PM ET ticker ISRLF CIK 0001915328
other material confidence high sentiment negative materiality 0.75

Israel Acquisitions extends deadline to Jan 2026; shareholders redeem ~$73M

Israel Acquisitions Corp

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

Israel Acquisitions Corp: Adopted Fourth Amended and Restated Memorandum and Articles of Association to extend the deadline to consummate an initial business combination up to twelve times, through January 18, 2026 (effective 2025-01-06).

Change
charter amendment
Effective
2025-01-06
Exact text from the filing
As approved by the Company’s shareholders at the Meeting on January 6, 2025, by special resolution, the Company amended the Company’s Third Amended and Restated Memorandum and Articles of Association on January 6, 2025, in its entirety, by adopting the Company’s Fourth Amended and Restated Memorandum and Articles of Association in the form set forth in Annex A to the definitive proxy statement filed with the Securities and Exchange Commission on December 23, 2024 (the “ Extension Amendment ”), reflecting the extension of the date by which the Company must consummate an initial business combination from the Termination Date up to twelve (12) times to January 18, 2026, with each Extension comprised of one month (i.e., for a period of time ending up to 36 months after the consummation of the Company’s initial public offering) for a total of twelve (12) months after the Termination Date (assuming an initial business combination has not occurred) (the “ Extension Amendment Proposal ”).
View on SEC.gov

Browse all governance changes →

Israel Acquisitions Corp filing history →

Source: SEC EDGAR
accession 0001104659-25-002170
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.